SC
RVMD icon

Stempoint Capital’s Revolution Medicines RVMD Stock Holding History

Stempoint Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.4M Buy
281,632
+219,600
+354% +$22.2M 5.26% 4
2025
Q4 		$4.94M Sell
62,032
-123,348
-67% -$8.09M 0.85% 41
2025
Q3 		$8.66M Buy
+185,380
New +$7.26M 1.75% 16
2025
Q2 		– Sell
-318,782
Closed -$11.3M – 78
2025
Q1 		$11.3M Buy
318,782
+125,247
+65% +$5.08M 3.6% 9
2024
Q4 		$8.47M Buy
193,535
+176,881
+1,062% +$8.93M 2.12% 16
2024
Q3 		$755K Buy
+16,654
New +$725K 0.23% 48

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return